A detailed history of First Horizon Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, First Horizon Corp holds 17 shares of AUPH stock, worth $201. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 80 78.75%
Holding current value
$201
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$7.47 - $13.14 $470 - $827
-63 Reduced 78.75%
17 $0
Q1 2021

May 11, 2021

BUY
$12.3 - $18.73 $984 - $1,498
80 New
80 $1,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.68B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.